BP
Ballentine Partners Portfolio holdings
AUM
$6.64B
1-Year Return
16.37%
This Quarter Return
+5.87%
1 Year Return
+16.37%
3 Year Return
+60.04%
5 Year Return
+90.6%
10 Year Return
+147.86%
AUM
$2.7B
AUM Growth
+$172M
(+6.8%)
Cap. Flow
+$29.5M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
65.64%
Holding
415
New
31
Increased
123
Reduced
204
Closed
12
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$17.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
$10M |
| 3 |
iShares Russell 3000 ETF
IWV
|
$6.39M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$5.1M |
| 5 |
Globe Life
GL
|
$4.28M |
Top Sells
| 1 |
iShares Russell 1000 ETF
IWB
|
$5.76M |
| 2 |
Vanguard Mega Cap Growth ETF
MGK
|
$5.35M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$3.77M |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
$1.82M |
| 5 |
Vanguard Small-Cap Growth ETF
VBK
|
$1.8M |
Sector Composition
| 1 | Technology | 3.2% |
| 2 | Financials | 2% |
| 3 | Healthcare | 1.7% |
| 4 | Consumer Discretionary | 1.21% |
| 5 | Industrials | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Blue Owl Capital
OBDC
$7.33B
| $404K | 0.02% |
29,328
| – | – |
|
252
ING
ING
$71B
| $402K | 0.01% |
32,923
-805
| -2% | -$9.83K |
|
253
Genuine Parts
GPC
$19.4B
| $401K | 0.01% |
3,479
-500
| -13% | -$57.6K |
|
254
Goldman Sachs
GS
$223B
| $399K | 0.01% |
1,219
-5
| -0.4% | -$1.64K |
|
255
T Rowe Price
TROW
$23.8B
| $398K | 0.01% |
2,318
+825
| +55% | +$142K |
|
256
Biogen
BIIB
$20.6B
| $395K | 0.01% |
1,410
-39
| -3% | -$10.9K |
|
257
W.W. Grainger
GWW
$47.5B
| $394K | 0.01% |
985
+1
| +0.1% | +$400 |
|
258
Repligen
RGEN
$7.01B
| $393K | 0.01% |
2,024
-193
| -9% | -$37.5K |
|
259
Prudential Financial
PRU
$37.2B
| $391K | 0.01% |
4,300
-51
| -1% | -$4.64K |
|
260
Zimmer Biomet
ZBH
$20.9B
| $391K | 0.01% |
2,518
-60
| -2% | -$9.32K |
|
261
S&P Global
SPGI
$164B
| $389K | 0.01% |
1,104
-535
| -33% | -$189K |
|
262
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $388K | 0.01% |
3,800
| – | – |
|
263
PACCAR
PCAR
$52B
| $385K | 0.01% |
6,218
+824
| +15% | +$51K |
|
264
Linde
LIN
$220B
| $384K | 0.01% |
1,371
-128
| -9% | -$35.9K |
|
265
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$300M
| $384K | 0.01% |
8,730
| – | – |
|
266
Cooper Companies
COO
$13.5B
| $383K | 0.01% |
3,976
-8
| -0.2% | -$771 |
|
267
Verisk Analytics
VRSK
$37.8B
| $383K | 0.01% |
2,168
+88
| +4% | +$15.5K |
|
268
Bunge Global
BG
$16.9B
| $382K | 0.01% |
4,819
-15
| -0.3% | -$1.19K |
|
269
Fortive
FTV
$16.2B
| $378K | 0.01% |
5,354
-99
| -2% | -$6.99K |
|
270
Diageo
DEO
$61.3B
| $377K | 0.01% |
2,295
+287
| +14% | +$47.1K |
|
271
Campbell Soup
CPB
$10.1B
| $368K | 0.01% |
7,322
-10,892
| -60% | -$547K |
|
272
McCormick & Company Non-Voting
MKC
$19B
| $362K | 0.01% |
4,055
+557
| +16% | +$49.7K |
|
273
KB Financial Group
KB
$28.5B
| $359K | 0.01% |
7,266
+176
| +2% | +$8.7K |
|
274
AstraZeneca
AZN
$253B
| $356K | 0.01% |
7,167
+323
| +5% | +$16K |
|
275
Cummins
CMI
$55.1B
| $355K | 0.01% |
1,369
-480
| -26% | -$124K |
|